Our previous discovery of USP9X as an ERG-stabilizing deubiquitinase [13] suggests that reduction of ERG protein levels by TRIM25-mediated proteasomal degradation is prevented by expression of USP9X in fusion-positive prostate cancer cells. Here, ERG is linked to prostate carcinoma.